← Back to Clinical Trials
Recruiting NCT04734821

NCT04734821 Fluorescence Image Guided Foregut Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04734821
Status Recruiting
Phase
Sponsor IHU Strasbourg
Condition Esophageal Cancer
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2021-04-01
Primary Completion 2026-03-31

Trial Parameters

Condition Esophageal Cancer
Sponsor IHU Strasbourg
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-04-01
Completion 2026-03-31
Interventions
Near Infra-Red Fluorescence Guided Surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

A high number of resected lymph nodes is an independent prognostic factor for improved survival after esophagectomy or gastrectomy for cancer. The quality of the lymphadenectomy is operator-dependent, as is the evaluation of the vascularization of the digestive structures that are anastomosed to restore digestive continuity after esophago-gastric resection. The aim of the study is to evaluate the impact of Indocyanine Green (ICG) and near infra-red (NIR) fluorescence imaging guidance in terms of number of lymph nodes resected and quality of gastrointestinal tract anastomoses in esophagogastric cancer surgery.

Eligibility Criteria

Inclusion Criteria: * Man or woman over 18 years old. * Patient with resectable primitive esophageal or gastric cancer confirmed by biopsy without distant metastases * Patient with no contraindications to anaesthesia and performance of esophageal and/or gastric surgery * Patient able to receive and understand information related to the study and give written informed consent. * Patient affiliated to the French social security system. Exclusion Criteria: * Patient undergoing emergency surgery (hemorrhage, occlusion or perforation). * Presence of distant metastasis * Patient at risk of allergy to indocyanine green or to other fluorescent compounds * Pregnant or lactating patient. * Patient in exclusion period (determined by a previous or a current study). * Patient under the protection of justice. * Patient under guardianship or trusteeship. * Patient deprived of liberty

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology